A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
Public ClinicalTrials.gov record NCT00618956. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Milnacipran 100 And 200 MG Daily in Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to accurately assess any changes in blood pressure and pulse at 100 and 200 mg daily dose of milnacipran in patients with fibromyalgia syndrome.
Study identification
- NCT ID
- NCT00618956
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2007 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 20, 2009
Started 2007
United States locations
- U.S. sites
- 38
- U.S. states
- 23
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site #032 | Birmingham | Alabama | 35205 | — |
| Site #035 | Birmingham | Alabama | 35209 | — |
| Site #038 | Phoenix | Arizona | 85004 | — |
| Site #019 | Pismo Beach | California | 93449 | — |
| Site #016 | San Diego | California | 92117 | — |
| Site #008 | Walnut Creek | California | 94598 | — |
| Site #037 | Delray Beach | Florida | 33484 | — |
| Site #025 | Jacksonville | Florida | 32216 | — |
| Site #009 | Ocala | Florida | 34471 | — |
| Site #011 | Orlando | Florida | 32806 | — |
| Site #036 | Tampa | Florida | 33614 | — |
| Site #006 | Atlanta | Georgia | 30328 | — |
| Site #030 | Libertyville | Illinois | 60048 | — |
| Site #018 | Evansville | Indiana | 47713 | — |
| Site #034 | Indianapolis | Indiana | 46254 | — |
| Site #004 | Worchester | Massachusetts | 01610 | — |
| Site #013 | Springfield | Missouri | 65807 | — |
| Site #021 | Albuquerque | New Mexico | 87108 | — |
| Site #005 | East Syracuse | New York | 13057 | — |
| Site #010 | Rochester | New York | 14618 | — |
| Site #029 | Charlotte | North Carolina | 28209 | — |
| Site #022 | Winston-Salem | North Carolina | 27103 | — |
| Site #002 | Cleveland | Ohio | 44122 | — |
| Site #017 | Toledo | Ohio | 13623 | — |
| Site #023 | Eugene | Oregon | 97401 | — |
| Site #007 | Eugene | Oregon | 97404 | — |
| Site #001 | Medford | Oregon | 97501 | — |
| Site #026 | Mechanicsburg | Pennsylvania | 17055 | — |
| Site #014 | Greer | South Carolina | 29651 | — |
| Site #027 | Bristol | Tennessee | 37620 | — |
| Site #024 | Memphis | Tennessee | 38119 | — |
| Site #031 | Nashville | Tennessee | 37203 | — |
| Site #028 | Sugarland | Texas | 77479 | — |
| Site #003 | Salt Lake City | Utah | 84102 | — |
| Site #012 | Woodstock | Vermont | 05091 | — |
| Site #020 | Richmond | Virginia | 23294 | — |
| Site #015 | Bellingham | Washington | 98226 | — |
| Site #033 | Racine | Wisconsin | 53406 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00618956, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2009 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00618956 live on ClinicalTrials.gov.